Allakos Inc. - Common Stock (NQ:ALLK)

0.3291 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allakos Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

ALLK Stock Earnings: Allakos Beats EPS for Q2 2024 ↗

August 07, 2024

ALLK stock results show that Allakos beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results

August 07, 2024

From Allakos Inc.

Via GlobeNewswire

Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile

June 25, 2024

From Allakos Inc.

Via GlobeNewswire

Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria

May 28, 2024

From Allakos Inc.

Via GlobeNewswire

ALLK Stock Earnings: Allakos Meets EPS for Q1 2024 ↗

May 09, 2024

ALLK stock results show that Allakos met analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ALLK Stock Earnings: Allakos Misses EPS for Q4 2023 ↗

March 14, 2024

ALLK stock results show that Allakos missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Where Allakos Stands With Analysts ↗

December 18, 2023

Via Benzinga

Allakos Provides Business Update and Reports First Quarter 2024 Financial Results

May 09, 2024

From Allakos Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 03, 2024

Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 01, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 15, 2024

We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!

Via InvestorPlace

What 4 Analyst Ratings Have To Say About Allakos ↗

November 28, 2023

Via Benzinga

3 Biotech Stocks to Dump Before They Go to Zero ↗

April 09, 2024

These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.

Via InvestorPlace

Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

March 14, 2024

From Allakos Inc.

Via GlobeNewswire

Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024

February 26, 2024

From Allakos Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 14, 2024

Via Benzinga

Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition

February 12, 2024

From Allakos Inc.

Via GlobeNewswire

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 17, 2024

Via Benzinga

Gold Down 1%; PNC Financial Posts Upbeat Earnings ↗

January 16, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 16, 2024

Via Benzinga

Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue ↗

January 16, 2024

U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to...

Via Benzinga

Topics Stocks

Why Is Allakos (ALLK) Stock Down 57% Today? ↗

January 16, 2024

Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing.

Via InvestorPlace

Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50% ↗

January 16, 2024

Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash...

Via Benzinga

Dow Dips 200 Points; Goldman Sachs Earnings Top Views ↗

January 16, 2024

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 16, 2024

Via Benzinga

Allakos Announces a Restructuring to Focus on Development of AK006

January 16, 2024

From Allakos Inc.

Via GlobeNewswire

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints

January 16, 2024

From Allakos Inc.

Via GlobeNewswire

Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive ↗

December 18, 2023

Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday.

Via Benzinga

Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results

November 13, 2023

From Allakos Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.